氢气吸入减轻内皮糖萼损伤并稳定失血性休克大鼠模型的血流动力学
该研究在大鼠失血性休克/复苏模型中,将平均动脉压降至35 mmHg持续60分钟后再复苏,休克后分别吸入氧气或氢气+氧气,并在有无XOR抑制剂或抗TNF-α单克隆抗体条件下观察。结果显示,氢气与XOR抑制剂均抑制MAP下降并提高生存率;氢气不影响XOR活性,且与XOR抑制剂疗效相加;氢气抑制血浆TNF-α和syndecan-1表达,但抗TNF-α单抗存在时氢气无额外疗效。结论提示氢气吸入稳定血流动力学、提高生存率不依赖XOR,其治疗作用部分由抑制TNF-α依赖性syndecan-1脱落介导。
要点
- 大鼠失血性休克/复苏模型中,休克后吸入氢气+氧气与吸入氧气相比,抑制MAP下降并提高复苏后6小时生存率。
- 氢气不影响XOR活性,氢气与XOR抑制剂的治疗效应呈相加作用,提示氢气作用不依赖XOR。
- 氢气抑制血浆TNF-α和syndecan-1表达;抗TNF-α单克隆抗体存在时氢气无额外治疗效应,提示其作用部分经TNF-α依赖性syndecan-1脱落途径。
- 该研究为动物实验,结果不能直接转化为临床推荐。
适用人群与场景
- 大鼠失血性休克/复苏模型:平均动脉压降至35 mmHg持续60分钟后再复苏。
处置流程与药物剂量
- 休克后吸入氢气+氧气或单纯氧气;部分组另加XOR抑制剂,部分组另加抗TNF-α单克隆抗体+氧气或氢气。
- 复苏后2小时检测XOR活性、嘌呤代谢物、细胞因子和syndecan-1;复苏后6小时评估生存率。
研究设计与关键结果
- 研究类型:大鼠失血性休克/复苏模型实验;干预:休克后吸入氧气或氢气+氧气,并在有无XOR抑制剂或抗TNF-α单克隆抗体条件下观察。
- 氢气与XOR抑制剂均抑制MAP下降并提高生存率;氢气不影响XOR活性,两者疗效相加。
- 氢气抑制血浆TNF-α和syndecan-1表达;抗TNF-α单克隆抗体存在时氢气无额外治疗效应。
证据类型、等级与局限
- 证据类型:动物实验(大鼠失血性休克/复苏模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该研究为动物实验,结果不能直接用于急诊/ICU临床决策;原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hydrogen gas (H2) inhalation during hemorrhage stabilizes post-resuscitation hemodynamics, improving short-term survival in a rat hemorrhagic shock and resuscitation (HS/R) model. However, the underlying molecular mechanism of H2 in HS/R is unclear. Endothelial glycocalyx (EG) damage causes hemodynamic failure associated with HS/R. In this study, we tested the hypothesis that H2 alleviates oxidative stress by suppressing xanthine oxidoreductase (XOR) and/or preventing tumor necrosis factor-alfa (TNF-α)-mediated syndecan-1 shedding during EG damage.
METHODS: HS/R was induced in rats by reducing mean arterial pressure (MAP) to 35 mm Hg for 60 min followed by resuscitation. Rats inhaled oxygen or H2 + oxygen after achieving shock either in the presence or absence of an XOR inhibitor (XOR-I) for both the groups. In a second test, rats received oxygen alone or antitumor necrosis factor (TNF)-α monoclonal antibody with oxygen or H2. Two hours after resuscitation, XOR activity, purine metabolites, cytokines, syndecan-1 were measured and survival rates were assessed 6 h after resuscitation.
RESULTS: H2 and XOR-I both suppressed MAP reduction and improved survival rates. H2 did not affect XOR activity and the therapeutic effects of XOR-I and H2 were additive. H2 suppressed plasma TNF-α and syndecan-1 expression; however, no additional H2 therapeutic effect was observed in the presence of anti-TNF-α monoclonal antibody.
CONCLUSIONS: H2 inhalation after shock stabilized hemodynamics and improved survival rates in an HS/R model independent of XOR. The therapeutic action of H2 was partially mediated by inhibition of TNF-α-dependent syndecan-1 shedding.
参考来源
- Tamura T, Sano M, Matsuoka T, et al. Hydrogen Gas Inhalation Attenuates Endothelial Glycocalyx Damage and Stabilizes Hemodynamics in a Rat Hemorrhagic Shock Model. Shock. 2020. PMID: 32804466. doi:10.1097/SHK.0000000000001459
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。